why choose us

First received: December 19, 2022

Clinical Trial: Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lung; Node

Study Type: OBSERVATIONAL


Official Title: Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Brief Summary: This study is an observational study of blood and tissue biomarkers.Investigators plan to evaluate the accuracy of lung cancer biomarkers found in the blood in determining if a lung nodule is cancer or benign.Investigators also plan to examine another biomarker found in the tumor tissue to identify participants after lung cancer surgery who have a high risk for recurrent cancer.Finally, investigators plan to determine if one of the blood-based biomarkers can be used to detect any late cancer recurrence.

Read more